Trustmark Corporation (TRMK)

BlackRock Inc. has invested $395.92 million in Trustmark Corporation, acquiring 8.61 million shares, which represents a 14.68% ownership stake. This investment positions institutional investors to collectively own 67.64% of the company. Trustmark recently exceeded quarterly earnings expectations, reporting $0.97 EPS and revenue up 4.8% year-over-year, and also declared a quarterly dividend of $0.25.

Bank of America Corp DE significantly increased its stake in Trustmark Corporation (NASDAQ:TRMK) by 121.1% in the first quarter, purchasing an additional 173,486 shares. This acquisition brings their total holdings to 316,772 shares valued at $13.35 million. Other institutional investors like Royal Bank of Canada and Goldman Sachs Group Inc. also adjusted their positions, indicating strong institutional interest in Trustmark, which currently holds a "Hold" consensus rating from analysts with a price target of $46.12.

Oppenheimer Asset Management Inc. has acquired 40,405 shares of Trustmark Corporation (NASDAQ:TRMK), valued at approximately $1.86 million, representing a new position for the firm. Other institutional investors like UBS Group AG and Wellington Management Group LLP have also adjusted their holdings in Trustmark. Analysts have set a consensus "Hold" rating for Trustmark with an average target price of $46.12.

Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP have reported beneficial ownership of 1,529,504 shares of Trustmark Corporation (TRMK) common stock, representing 2.61% of the class. This disclosure, made via an amended Schedule 13G filing, indicates that the Wellington entities have shared voting and shared dispositive power over these shares, which are held by clients of their investment advisers. No single client is known to hold more than five percent of Trustmark's common stock.

Trustmark Corporation (NASDAQ:TRMK) has received an average "Hold" rating from analysts, with five out of seven recommending holding the stock and two suggesting a buy. The average 12-month price target is $46.13, slightly below its recent trading price of $47.42. The company recently surpassed quarterly earnings and revenue expectations, reporting $0.97 EPS and $213.38 million in revenue, and declared a quarterly dividend of $0.25.